TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.43 0.27 (62.14%) 0.0 (-0.01%) 0.03 (4.27%) 0.0 (0.23%) 0.01 (1.71%) 0.42 (94.36%) -0.14 (-16.57%) -0.14 (-16.57%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.3635
Diluted P/E:
-0.3635
RSI(14) 1m:
62.77
VWAP:
0.7
RVol:

Events

Period Kind Movement Occurred At
1m Price increase 1m 0.62 +0.01 (+1.71%) Oct 15 17:21
1m Price increase 1m 0.62 +0.01 (+1.71%) Oct 15 17:21
1m Price increase 1m 0.62 +0.01 (+1.71%) Oct 15 17:21
1m Price increase 1m 0.62 +0.01 (+1.71%) Oct 15 17:21
10m Price decrease 10m 0.61 -0.03 (-5.39%) Oct 15 17:20

Related News